top of page
The Professional Network for Healthcare Experts
FDA approves Sun Pharma Ilumya for adults with active psoriatic arthritis
The FDA has approved Sun Pharma's Ilumya for adults with active psoriatic arthritis, expanding the IL-23 inhibitor beyond its established plaque psoriasis indication.
nuaxia
5 days ago2 min read
China approves Bio-Thera BAT2306 as world's first secukinumab biosimilar
China has approved Bio-Thera's BAT2306 as the first secukinumab biosimilar authorised by a major regulator worldwide, opening a new biosimilar competition category.
nuaxia
Oct 272 min read
bottom of page